These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 29198023)
1. The Use of Stimulant Medication to Treat Attention-Deficit/Hyperactivity Disorder in Elite Athletes: A Performance and Health Perspective. Garner AA; Hansen AA; Baxley C; Ross MJ Sports Med; 2018 Mar; 48(3):507-512. PubMed ID: 29198023 [TBL] [Abstract][Full Text] [Related]
2. Considerations in the Use of Stimulants in Sport. Reardon CL; Factor RM Sports Med; 2016 May; 46(5):611-7. PubMed ID: 26712509 [TBL] [Abstract][Full Text] [Related]
4. Considerations in the Care of Athletes With Attention Deficit Hyperactivity Disorder. Pujalte GGA; Maynard JR; Thurston MJ; Taylor WC; Chauhan M Clin J Sport Med; 2019 May; 29(3):245-256. PubMed ID: 29189334 [TBL] [Abstract][Full Text] [Related]
9. Attention deficit hyperactivity disorder and the athlete: an American Medical Society for Sports Medicine position statement. Putukian M; Kreher JB; Coppel DB; Glazer JL; McKeag DB; White RD Clin J Sport Med; 2011 Sep; 21(5):392-401. PubMed ID: 21892014 [TBL] [Abstract][Full Text] [Related]
10. Attention deficit hyperactivity disorder in sport: a review. Corrigan B Int J Sports Med; 2003 Oct; 24(7):535-40. PubMed ID: 12968213 [TBL] [Abstract][Full Text] [Related]
11. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics. Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211 [TBL] [Abstract][Full Text] [Related]
12. Neurocognitive Deficits Associated With ADHD in Athletes: A Systematic Review. Poysophon P; Rao AL Sports Health; 2018; 10(4):317-326. PubMed ID: 29337649 [TBL] [Abstract][Full Text] [Related]
13. Physician perceptions of the use of medications for attention deficit hyperactivity disorder. Stockl KM; Hughes TE; Jarrar MA; Secnik K; Perwien AR J Manag Care Pharm; 2003; 9(5):416-23. PubMed ID: 14613439 [TBL] [Abstract][Full Text] [Related]
14. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy. Mohammadi M; Akhondzadeh S Acta Med Iran; 2011; 49(8):487-98. PubMed ID: 22009816 [TBL] [Abstract][Full Text] [Related]
15. Effects of stimulant medication on divergent and convergent thinking tasks related to creativity in adults with attention-deficit hyperactivity disorder. McBride M; Appling C; Ferguson B; Gonzalez A; Schaeffer A; Zand A; Wang D; Sam A; Hart E; Tosh A; Fontcha I; Parmacek S; Beversdorf D Psychopharmacology (Berl); 2021 Dec; 238(12):3533-3541. PubMed ID: 34477886 [TBL] [Abstract][Full Text] [Related]
16. The potential for misuse and abuse of medications in ADHD: a review. Clemow DB; Walker DJ Postgrad Med; 2014 Sep; 126(5):64-81. PubMed ID: 25295651 [TBL] [Abstract][Full Text] [Related]
17. Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study. Rose SR; Reeves G; Gut R; Germak J J Pediatr; 2015 Dec; 167(6):1389-96. PubMed ID: 26394822 [TBL] [Abstract][Full Text] [Related]